Leadless Pacemakers Market To Reach $1.74 Billion By 2030

Leadless Pacemakers Market Growth & Trends 

The global leadless pacemakers market size is expected to reach USD 1.74 billion by 2030, growing at a CAGR of 15.5% from 2024 to 2030, based on a new report by Grand View Research, Inc. This growth is attributed to technological advancements, rising prevalence of heart diseases, and a preference for minimally invasive procedures. Moreover, the growing aging population globally propels the demand for leadless pacemakers, as bradycardia is common in the geriatric population. According to the Cleveland Clinic, approximately half a million of the geriatric population show the symptoms of bradycardia, thereby driving the industry.

Wireless or leadless pacemakers, frequently used in adult patients, have emerged as a potentially safe and efficient temporary alternative for children experiencing bradycardia, as revealed by research featured in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal affiliated with the American Heart Association. This development is expected to be a potential driver for the market growth.

In addition, growing business initiatives by companies for leadless pacemakers propel the industry's growth. For instance, in January 2024, Medtronic plc announced it had received the CE (Conformite Europeenne) Mark for its Micra AV2 and Micra VR2, leadless pacemakers.The Micra AV2 and Micra VR2, which are recognized as the smallest pacemakers globally, offer extended battery life and simplified programming in comparison to earlier models of Micra pacemakers. Despite these advancements, they retain the numerous advantages of leadless pacing, including a reduction in complications when compared to traditional pacemakers.

 Request a free sample copy or view report summary: Leadless Pacemakers Market Report

Leadless Pacemakers Market Report Highlights

• Based on the pacing chamber, single chamber accounted for the largest revenue market share of 54.84% in 2023 due to the suitability for a broader range of patients with bradycardia or heart block

• Based on the pacing chamber, the dual chamber segment is expected to grow at the fastest CAGR of 16.3% during the forecast period owing to their ability to address a broader range of cardiac conditions

• Based on the end-use, the hospital segment accounted for the largest market share of 88.86% in 2023 due to their functioning as crucial centers for patient recruitment and engagement in these trials

• In 2023, North America dominated with a share of 54.92% due to technological advancements, increasing heart diseases, and accessibility and availability of skilled professionals. Asia Pacific is expected to grow at the fastest CAGR of 16.9% during the forecast period the growing collaborations, increasing health expenditure, government initiatives, increasing CVD, and geographic expansion 

Leadless Pacemakers Market Segmentation

Grand View Research has segmented the global leadless pacemakers market based on pacing chamber, end-use, and region:

Leadless Pacemakers Pacing Chamber Outlook (Revenue, USD Million, 2018 - 2030­)

• Single Chamber

• Dual Chamber

Leadless Pacemakers End-use Outlook (Revenue, USD Million, 2018 - 2030­)

• Hospitals

• Outpatient Facilities

Leadless Pacemakers Regional Outlook (Revenue, USD Million, 2018 - 2030­)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Leadless Pacemakers Market

• Abbott

• Medtronic

• EBR Systems, Inc.

• Boston Scientific Corporation

• MicroPort Scientific Corporation